Material-Driven Therapeutics: Functional Nanomaterial Design Paradigms Revolutionizing Osteosarcoma Treatment
Osteosarcoma (OS), a prevalent primary malignant bone tumor in children and adolescents, has maintained consistent treatment protocols since the 1970s combining surgery, chemotherapy, and radiotherapy. While effective for localized tumors, these strategies show limited efficacy against metastatic or...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Journal of Functional Biomaterials |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-4983/16/6/213 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839653703027523584 |
|---|---|
| author | Zewei Zhang Fang He Wenqu Li Beibei Liu Cheng Deng Xiaojuan Qin |
| author_facet | Zewei Zhang Fang He Wenqu Li Beibei Liu Cheng Deng Xiaojuan Qin |
| author_sort | Zewei Zhang |
| collection | DOAJ |
| description | Osteosarcoma (OS), a prevalent primary malignant bone tumor in children and adolescents, has maintained consistent treatment protocols since the 1970s combining surgery, chemotherapy, and radiotherapy. While effective for localized tumors, these strategies show limited efficacy against metastatic or recurrent cases. Although emerging immunotherapies (PD-1 inhibitors, CAR-T-cell therapy) demonstrate therapeutic potential, their clinical impact remains constrained by the tumor’s low immunogenicity and immunosuppressive microenvironment, resulting in suboptimal response rates. The disease’s aggressive nature and propensity for pulmonary metastasis contribute to poor prognosis, with survival rates showing negligible improvement over five decades despite therapeutic advances, creating substantial clinical and socioeconomic challenges. Recent developments in nanomedicine offer promising solutions for OS treatment optimization. This review systematically examines nanomaterial applications in OS therapy through a materials science lens, analyzing mechanism-specific interventions and highlighting notable advancements from the past five years. We critically evaluate current strategies for enhancing therapeutic efficacy while reducing toxicity profiles, ultimately outlining translational pathways and key challenges in clinical adaptation. The analysis establishes a framework for developing next-generation nanotherapeutic platforms to address persistent limitations in OS management. |
| format | Article |
| id | doaj-art-1fc7f1f84a1842f4b15d7006af0528d0 |
| institution | Matheson Library |
| issn | 2079-4983 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Functional Biomaterials |
| spelling | doaj-art-1fc7f1f84a1842f4b15d7006af0528d02025-06-25T13:59:36ZengMDPI AGJournal of Functional Biomaterials2079-49832025-06-0116621310.3390/jfb16060213Material-Driven Therapeutics: Functional Nanomaterial Design Paradigms Revolutionizing Osteosarcoma TreatmentZewei Zhang0Fang He1Wenqu Li2Beibei Liu3Cheng Deng4Xiaojuan Qin5Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, ChinaDepartment of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, ChinaDepartment of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, ChinaDepartment of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, ChinaDepartment of Medical Ultrasound, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, ChinaDepartment of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, ChinaOsteosarcoma (OS), a prevalent primary malignant bone tumor in children and adolescents, has maintained consistent treatment protocols since the 1970s combining surgery, chemotherapy, and radiotherapy. While effective for localized tumors, these strategies show limited efficacy against metastatic or recurrent cases. Although emerging immunotherapies (PD-1 inhibitors, CAR-T-cell therapy) demonstrate therapeutic potential, their clinical impact remains constrained by the tumor’s low immunogenicity and immunosuppressive microenvironment, resulting in suboptimal response rates. The disease’s aggressive nature and propensity for pulmonary metastasis contribute to poor prognosis, with survival rates showing negligible improvement over five decades despite therapeutic advances, creating substantial clinical and socioeconomic challenges. Recent developments in nanomedicine offer promising solutions for OS treatment optimization. This review systematically examines nanomaterial applications in OS therapy through a materials science lens, analyzing mechanism-specific interventions and highlighting notable advancements from the past five years. We critically evaluate current strategies for enhancing therapeutic efficacy while reducing toxicity profiles, ultimately outlining translational pathways and key challenges in clinical adaptation. The analysis establishes a framework for developing next-generation nanotherapeutic platforms to address persistent limitations in OS management.https://www.mdpi.com/2079-4983/16/6/213osteosarcomananomaterialstreatmentmalignant bone tumor |
| spellingShingle | Zewei Zhang Fang He Wenqu Li Beibei Liu Cheng Deng Xiaojuan Qin Material-Driven Therapeutics: Functional Nanomaterial Design Paradigms Revolutionizing Osteosarcoma Treatment Journal of Functional Biomaterials osteosarcoma nanomaterials treatment malignant bone tumor |
| title | Material-Driven Therapeutics: Functional Nanomaterial Design Paradigms Revolutionizing Osteosarcoma Treatment |
| title_full | Material-Driven Therapeutics: Functional Nanomaterial Design Paradigms Revolutionizing Osteosarcoma Treatment |
| title_fullStr | Material-Driven Therapeutics: Functional Nanomaterial Design Paradigms Revolutionizing Osteosarcoma Treatment |
| title_full_unstemmed | Material-Driven Therapeutics: Functional Nanomaterial Design Paradigms Revolutionizing Osteosarcoma Treatment |
| title_short | Material-Driven Therapeutics: Functional Nanomaterial Design Paradigms Revolutionizing Osteosarcoma Treatment |
| title_sort | material driven therapeutics functional nanomaterial design paradigms revolutionizing osteosarcoma treatment |
| topic | osteosarcoma nanomaterials treatment malignant bone tumor |
| url | https://www.mdpi.com/2079-4983/16/6/213 |
| work_keys_str_mv | AT zeweizhang materialdriventherapeuticsfunctionalnanomaterialdesignparadigmsrevolutionizingosteosarcomatreatment AT fanghe materialdriventherapeuticsfunctionalnanomaterialdesignparadigmsrevolutionizingosteosarcomatreatment AT wenquli materialdriventherapeuticsfunctionalnanomaterialdesignparadigmsrevolutionizingosteosarcomatreatment AT beibeiliu materialdriventherapeuticsfunctionalnanomaterialdesignparadigmsrevolutionizingosteosarcomatreatment AT chengdeng materialdriventherapeuticsfunctionalnanomaterialdesignparadigmsrevolutionizingosteosarcomatreatment AT xiaojuanqin materialdriventherapeuticsfunctionalnanomaterialdesignparadigmsrevolutionizingosteosarcomatreatment |